David Jungck

505 total citations
26 papers, 413 citations indexed

About

David Jungck is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, David Jungck has authored 26 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 9 papers in Immunology. Recurrent topics in David Jungck's work include Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers), Asthma and respiratory diseases (10 papers) and Pediatric health and respiratory diseases (8 papers). David Jungck is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers), Asthma and respiratory diseases (10 papers) and Pediatric health and respiratory diseases (8 papers). David Jungck collaborates with scholars based in Germany, Sweden and United Kingdom. David Jungck's co-authors include Jürgen Knobloch, Andrea Koch, Erich Stoelben, Justus Strauch, Jan Rupp, Yingfeng Lin, Katja Müller, M Feldmann, Elke K. H. Schweda and Klaus Müller and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, International Journal of Molecular Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

David Jungck

26 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Jungck Germany 11 186 131 113 91 68 26 413
Christos Rossios United Kingdom 11 284 1.5× 310 2.4× 200 1.8× 135 1.5× 47 0.7× 21 727
Fengsen Li China 15 239 1.3× 99 0.8× 158 1.4× 129 1.4× 60 0.9× 59 540
Leonard Guarente Italy 5 99 0.5× 140 1.1× 153 1.4× 42 0.5× 13 0.2× 10 392
G. F. Korytina Russia 12 178 1.0× 102 0.8× 160 1.4× 27 0.3× 47 0.7× 78 432
Xuanna Zhao China 11 79 0.4× 78 0.6× 126 1.1× 34 0.4× 12 0.2× 19 325
Elise M. Messier United States 10 217 1.2× 59 0.5× 246 2.2× 183 2.0× 19 0.3× 11 599
Thomas Colley United Kingdom 9 97 0.5× 88 0.7× 141 1.2× 25 0.3× 9 0.1× 10 398
T.S. Blackwell United States 7 132 0.7× 33 0.3× 98 0.9× 162 1.8× 12 0.2× 10 400
Carlos Torres-Lozano Mexico 5 124 0.7× 143 1.1× 84 0.7× 123 1.4× 30 0.4× 10 361
Suffwan Eltom United Kingdom 9 208 1.1× 107 0.8× 202 1.8× 114 1.3× 46 0.7× 9 448

Countries citing papers authored by David Jungck

Since Specialization
Citations

This map shows the geographic impact of David Jungck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jungck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jungck more than expected).

Fields of papers citing papers by David Jungck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Jungck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jungck. The network helps show where David Jungck may publish in the future.

Co-authorship network of co-authors of David Jungck

This figure shows the co-authorship network connecting the top 25 collaborators of David Jungck. A scholar is included among the top collaborators of David Jungck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Jungck. David Jungck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knobloch, Jürgen, David Jungck, Jan Rupp, et al.. (2019). The monocyte-dependent immune response to bacteria is suppressed in smoking-induced COPD. Journal of Molecular Medicine. 97(6). 817–828. 10 indexed citations
2.
Knobloch, Jürgen, et al.. (2017). The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine. Current Molecular Medicine. 17(2). 108–117. 13 indexed citations
3.
Jungck, David, et al.. (2017). HDL serum levels are significantly lower in patients with COPD than in never-smokers. Epidemiology. PA1204–PA1204. 1 indexed citations
4.
Knobloch, Jürgen, et al.. (2016). Simvastatin requires activation in accessory cells to modulate T-cell responses in asthma and COPD. European Journal of Pharmacology. 788. 294–305. 4 indexed citations
5.
Knobloch, Jürgen, et al.. (2016). TNFα-induced airway smooth muscle cell proliferation depends on endothelin receptor signaling, GM-CSF and IL-6. Biochemical Pharmacology. 116. 188–199. 23 indexed citations
6.
Knobloch, Jürgen, et al.. (2016). Serum BNP levels in COPD, asthma-COPD-overlap-syndrome, smokers and never-smokers. PA1000–PA1000. 1 indexed citations
7.
Jungck, David, et al.. (2015). Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects. European Journal of Pharmacology. 768. 123–130. 10 indexed citations
8.
Jungck, David, et al.. (2015). Endothelin Receptor B Protects Granulocyte Macrophage Colony-Stimulating Factor mRNA from Degradation. Journal of Pharmacology and Experimental Therapeutics. 353(3). 564–572. 1 indexed citations
9.
Jungck, David, et al.. (2014). COPD Assessment Test korreliert mit FEV1 und Exazerbationsrate von Patienten mit Asthma bronchiale. Pneumologie. 68(S 01). 1 indexed citations
10.
Knobloch, Jürgen, Yingfeng Lin, David Jungck, et al.. (2013). Inflammatory Responses of Airway Smooth Muscle Cells and Effects of Endothelin Receptor Antagonism. American Journal of Respiratory Cell and Molecular Biology. 49(1). 114–127. 17 indexed citations
11.
Knobloch, Jürgen, M Feldmann, David Jungck, et al.. (2013). Endothelin Receptor Antagonists Attenuate the Inflammatory Response of Human Pulmonary Vascular Smooth Muscle Cells to Bacterial Endotoxin. Journal of Pharmacology and Experimental Therapeutics. 346(2). 290–299. 7 indexed citations
12.
Knobloch, Jürgen, et al.. (2011). IL-5 release of CD4+ non-effector lymphocytes is increased in COPD — modulating effects of moxifloxacin and dexamethasone. International Immunopharmacology. 11(4). 444–448. 10 indexed citations
13.
Knobloch, Jürgen, David Jungck, & Andrea Koch. (2011). Apoptosis Induction by Thalidomide: Critical for Limb Teratogenicity but Therapeutic Potential in Idiopathic Pulmonary Fibrosis?. Current Molecular Pharmacology. 4(1). 26–61. 16 indexed citations
14.
Knobloch, Jürgen, et al.. (2011). Resveratrol Impairs the Release of Steroid-resistant Cytokines from Bacterial Endotoxin-Exposed Alveolar Macrophages in Chronic Obstructive Pulmonary Disease. Basic & Clinical Pharmacology & Toxicology. 109(2). 138–143. 48 indexed citations
15.
Knobloch, Jürgen, et al.. (2011). Apoptosis Induction by Thalidomide: Critical for Limb Teratogenicity but Therapeutic Potential in Idiopathic Pulmonary Fibrosis?. Current Molecular Pharmacology. 4(1). 26–61. 1 indexed citations
16.
17.
Knobloch, Jürgen, David Jungck, Katja Müller, et al.. (2010). The T-Helper Cell Type 1 Immune Response to Gram-Negative Bacterial Infections Is Impaired in COPD. American Journal of Respiratory and Critical Care Medicine. 183(2). 204–214. 56 indexed citations
18.
Knobloch, Jürgen, David Jungck, Yingfeng Lin, et al.. (2010). Resveratrol Impairs the Release of Steroid-Resistant Inflammatory Cytokines from Human Airway Smooth Muscle Cells in Chronic Obstructive Pulmonary Disease. Journal of Pharmacology and Experimental Therapeutics. 335(3). 788–798. 66 indexed citations
19.
20.
Knobloch, Jürgen, Harry P. F. Peters, David Jungck, et al.. (2009). TNF -induced GM-CSF release from human airway smooth muscle cells depends on activation of an ET-1 autoregulatory positive feedback mechanism. Thorax. 64(12). 1044–1052. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christos Rossios Breakdown of academic impact, for papers by Fengsen Li Breakdown of academic impact, for papers by Leonard Guarente Breakdown of academic impact, for papers by G. F. Korytina Breakdown of academic impact, for papers by Xuanna Zhao Breakdown of academic impact, for papers by Elise M. Messier Breakdown of academic impact, for papers by Thomas Colley Breakdown of academic impact, for papers by T.S. Blackwell Breakdown of academic impact, for papers by Carlos Torres-Lozano Breakdown of academic impact, for papers by Suffwan Eltom
Rankless by CCL
2026